Global Radiation Oncology Treatment Planning Software Market – Industry Trends and Forecast to 2030

Global Radiation Oncology Treatment Planning Software Market, By Product and Services (Software, Patient Information Systems, Treatment Planning System, Professional Services, Consulting/Optimization Services, Implementation Services, Post-Sale and Maintenance Services), Therapy Type (Stereotactic Radiosurgery (SRS), 3-D Conformal Radiation Therapy (3D CRT), Brachytherapy, Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT),Others, End-User (Hospitals and Physician’s Offices, Research Centers, Government Institutions, Cancer Treatment Centres, Others) – Industry Trends and Forecast to 2030. 

Radiation Oncology Treatment Planning Software Market Analysis and Size

According to the International Agency for Research on Cancer, the incidence of lung cancer is expected to rise from 2.21 million in 2020 to 2.9 million by 2030. Radiation therapy is used to treat both NSCLC and SCLC, either alone or in combination with chemotherapy, post-surgery, or pre-surgery. Brachytherapy is used to treat gynecological, breast, lung, penile, and other types of cancer. In 2020, IBRT for the treatment of prostate cancer accounted for the largest share.

Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Radiation Oncology Treatment Planning Software Market Scope and Segmentation  

Market Definition

Radiation therapy for cancer patients is administered with radiation oncology treatment planning software. It can control radiations such as photons, FFF beams, electrons, low-dose-rate external beams for brachytherapy, protons, and cobalt treatment. The software decreases inter-planner variability, shortens planning times, and enhances patient-centered plan quality.

Global Radiation Oncology Treatment Planning Software Market Dynamics

Drivers

• Rise in research and development activities

Market participants are focusing on research and development activities, which is driving market growth. For instance, Mayo Clinic and Google Health announced a joint initiative in October 2020 to conduct research into the application of artificial intelligence (AI) to radiation therapy planning, a critical component of cancer care. In a similar vein, Siris Medical, Inc. released new PlanMDTM software in 2018, allowing radiation oncology clinical teams to leverage patient data and artificial intelligence to empower their treatment decisions more efficiently. It is also the first and only tool that allows the physician to see the effect of contour editing in real-time, without the need for re-optimization or replanning.

• Rising need for cutting-edge and efficient cancer treatments

The rising need for cutting-edge and efficient cancer treatments around the world, an increase in the number of cancer patients, and a sizable expenditure budget for them are the primary factors propelling the radiation oncology treatment planning software market. Furthermore, the fact that the software provides advanced care through beam planning and automated calculations and is significantly more accurate, quick, and efficient accelerates market growth from 2022 to 2030.

Opportunities

• Increase in cancer treatment

Another factor driving up demand for treatment planning systems is the software's ability to regulate radiation beams such as protons, photons, FFF beams, electrons, low-dose-rate brachytherapy external beams, and cobalt therapy in cancer treatment.

Another driver propelling the market is the growing acceptance of proton therapy, since these beams are increasingly favoured for cancer treatment. Medical and research institutions are implementing radiation oncology treatment planning software to lessen collateral tissue damage and the negative effects of radiation therapy to the patients, creating an opportunity for market players.

Restraints/Challenges

• High cost

High costs and a shortage of skilled labour to plan and operate software are expected to hamper the market growth. In addition, lower adoption rates in developing economies may pose a challenge to the radiation oncology treatment planning software market during the forecast period.

This radiation oncology treatment planning software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the radiation oncology treatment planning software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Radiation Oncology Treatment Planning Software Market Scope

The radiation oncology treatment planning software market is segmented on the basis of products and services, therapy type and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

• Software
• Patient Information Systems
• Treatment Planning System
• Professional Services
• Consulting/Optimization Services
• Implementation Services
• Post-Sale and Maintenance Services

Therapy Type

• Stereotactic Radiosurgery (SRS)
• 3-D Conformal Radiation Therapy (3D CRT)
• Brachytherapy
• Stereotactic Body Radiotherapy (SBRT)
• Intensity Modulated Radiation Therapy (IMRT)
• Volumetric Modulated Arc Therapy (VMAT)
• Others

 End-User

• Hospitals and Physician’s Offices
• Research Centers
• Government Institutions
• Cancer Treatment Centres
• Others

Radiation Oncology Treatment Planning Software Market Regional Analysis/Insights

The radiation oncology treatment planning software market is analyzed and market size insights and trends are provided by country, products and services, therapy type and end-users as referenced above.

The countries covered in the radiation oncology treatment planning software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates radiation oncology treatment planning software market because of higher presence of cancer patients as well as cancer treatment providing centers and institutes.

 Asia-Pacific is estimated to grow in the forecast period of 2023-2030 due to growing adoption of radiation therapy for cancer treatment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value cain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Radiation Oncology Treatment Planning Software Market Share Analysis

The radiation oncology treatment planning software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to radiation oncology treatment planning software market.

Some of the major players operating in the radiation oncology treatment planning software market are:

• DOSIsoft SA (France)
• Koninklijke Philips N.V. (Netherlands)
• MIM Software Inc. (U.S.)
• RaySearch Laboratories (Sweden)
• Elekta (Sweden)
• Brainlab AG (Germany)
• IBA Worldwide (Belgium)
• Accuray Incorporated (U.S.)
• VIEWRAY TECHNOLOGIES, INC. (U.S.)
• Varian Medical Systems, Inc. (U.K.)
• Institut Straumann AG (Switzerland)
• Nobel Biocare Services AG (Switzerland)
• CAMLOG Biotechnologies GmbH (U.S.)
• medentis medical GmbH (Germany)
• BEGO Medical GmbH (Germany)
• Dentsply Sirona. (U.S.)
• Zimmer Biomet (U.S.)